Skip to main content
. Author manuscript; available in PMC: 2021 Aug 20.
Published in final edited form as: Kidney360. 2020 Jun 25;1(6):561–568. doi: 10.34067/KID.0000272019

Table 1. American College of Radiology 2018 classification of gadolinium-based contrast agents into groups I, II, and III.

Group Classification
Group I Gadodiamide, gadopentetate dimeglumine
Group II Gadobenate dimeglumine, gadobutrol, gadoterate acid, gadoteridol
Group III Gadoxetate